Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

被引:342
作者
van Nimwegen, Frederika A. [1 ]
Schaapveld, Michael [1 ,2 ]
Cutter, David J. [7 ,8 ]
Janus, Cecile P. M. [4 ]
Krol, Augustinus D. G. [5 ]
Hauptmann, Michael [1 ]
Kooijman, Karen [1 ]
Roesink, Judith [3 ]
van der Maazen, Richard [6 ]
Darby, Sarah C. [7 ]
Aleman, Berthe M. P. [1 ]
van Leeuwen, Flora E. [1 ]
机构
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Netherlands Comprehens Canc Org, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
[4] Erasmus MC Canc Inst, Rotterdam, Netherlands
[5] Leiden Univ, Med Ctr, Leiden, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[7] Univ Oxford, Oxford, England
[8] Oxford Univ Hosp NHS Trust, Oxford, England
关键词
LONG-TERM; CARDIOVASCULAR-DISEASE; ADULT SURVIVORS; FOLLOW-UP; CARDIAC EVENTS; RADIOTHERAPY; CHILDHOOD; MORTALITY; CARDIOTOXICITY; THERAPY;
D O I
10.1200/JCO.2015.63.4444
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Cardiovascular diseases are increasingly recognized as late effects of Hodgkin lymphoma (HL) treatment. The purpose of this study was to identify the risk factors for coronary heart disease (CHD) and to quantify the effects of radiation dose to the heart, chemotherapy, and other cardiovascular risk factors. Patients and Methods We conducted a nested case-control study in a cohort of 2,617 5-year HL survivors, treated between 1965 and 1995. Cases were patients diagnosed with CHD as their first cardiovascular event after HL. Detailed treatment information was collected from medical records of 325 cases and 1,204 matched controls. Radiation charts and simulation radiographs were used to estimate in-field heart volume and mean heart dose (MHD). A risk factor questionnaire was sent to patients still alive. Results The median interval between HL and CHD was 19.0 years. Risk of CHD increased linearly with increasing MHD (excess relative risk [ERR]) per Gray, 7.4%; 95% CI, 3.3% to 14.8%). This results in a 2.5-fold increased risk of CHD for patients receiving a MHD of 20 Gy from mediastinal radiotherapy, compared with patients not treated with mediastinal radiotherapy. ERRs seemed to decrease with each tertile of age at treatment (ERR/ Gy(<27.5years), 20.0%; ERR/ Gy(27.5-36.4years), 8.8%; ERR/ Gy(36.5-50.9years), 4.2%; P-interaction = .149). Having >= 1 classic CHD risk factor (diabetes mellitus, hypertension, or hypercholesterolemia) independently increased CHD risk (rate ratio, 1.5; 95% CI, 1.1 to 2.1). A high level of physical activity was associated with decreased CHD risk (rate ratio, 0.5; 95% CI, 0.3 to 0.8). Conclusion The linear radiation dose-response relationship identified can be used to predict CHD risk for future HL patients and survivors. Appropriate early management of CHD risk factors and stimulation of physical activity may reduce CHD risk in HL survivors. (C) 2015 by American Society of Clinical Oncology
引用
收藏
页码:235 / U89
页数:12
相关论文
共 33 条
[1]   Late cardiotoxicity after treatment for Hodgkin lymphoma [J].
Aleman, Berthe M. P. ;
van den Belt-Dusebout, Alexandra W. ;
De Bruin, Marie L. ;
van 't Veer, Mars B. ;
Baaijens, Margreet H. A. ;
de Boers, Jan Paul ;
Hart, Augustinus A. M. ;
Klokman, Willem J. ;
Kuenen, Marianne A. ;
Ouwens, Gabey M. ;
Bartelink, Harry ;
van Leeuwen, Flora E. .
BLOOD, 2007, 109 (05) :1878-1886
[2]   Long-term cause-specific mortality of patients treated for Hodgkin's disease [J].
Aleman, BMP ;
van den Belt-Dusebout, AW ;
Klokman, WJ ;
van't Veer, MB ;
Bartelink, H ;
van Leeuwen, FE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3431-3439
[3]  
[Anonymous], 2009, COMM TERM CRIT ADV E
[4]  
[Anonymous], DUTCH CANC FIG
[5]   Aging and Risk of Severe, Disabling, Life-Threatening, and Fatal Events in the Childhood Cancer Survivor Study [J].
Armstrong, Gregory T. ;
Kawashima, Toana ;
Leisenring, Wendy ;
Stratton, Kayla ;
Stovall, Marilyn ;
Hudson, Melissa M. ;
Sklar, Charles A. ;
Robison, Leslie L. ;
Oeffinger, Kevin C. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (12) :1218-+
[6]   Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer [J].
Armstrong, Gregory T. ;
Oeffinger, Kevin C. ;
Chen, Yan ;
Kawashima, Toana ;
Yasui, Yutaka ;
Leisenring, Wendy ;
Stovall, Marilyn ;
Chow, Eric J. ;
Sklar, Charles A. ;
Mulrooney, Daniel A. ;
Mertens, Ann C. ;
Border, William ;
Durand, Jean-Bernard ;
Robison, Leslie L. ;
Meacham, Lillian R. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) :3673-+
[7]  
Cutter DJ, 2015, JNCI-J NATL CANCER I, V107, DOI [10.1093/jnci/djv008, 10.1016/j.asams.2015.03.009]
[8]   Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer [J].
Darby, Sarah C. ;
Ewertz, Marianne ;
McGale, Paul ;
Bennet, Anna M. ;
Blom-Goldman, Ulla ;
Bronnum, Dorthe ;
Correa, Candace ;
Cutter, David ;
Gagliardi, Giovanna ;
Gigante, Bruna ;
Jensen, Maj-Britt ;
Nisbet, Andrew ;
Peto, Richard ;
Rahimi, Kazem ;
Taylor, Carolyn ;
Hall, Per .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) :987-998
[9]   RADIATION-RELATED HEART DISEASE: CURRENT KNOWLEDGE AND FUTURE PROSPECTS [J].
Darby, Sarah C. ;
Cutter, David J. ;
Boerma, Marjan ;
Constine, Louis S. ;
Fajardo, Luis F. ;
Kodama, Kazunori ;
Mabuchi, Kiyohiko ;
Marks, Lawrence B. ;
Mettler, Fred A. ;
Pierce, Lori J. ;
Trott, Klaus R. ;
Yeh, Edward T. H. ;
Shore, Roy E. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03) :656-665
[10]   Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma [J].
De Bruin, Marie L. ;
Dorresteijn, Lucille D. A. ;
van't Veer, Mars B. ;
Krol, Augustinus D. G. ;
van der Pal, Helena J. ;
Kappelle, Arnoud C. ;
Boogerd, Willem ;
Aleman, Berthe M. P. ;
van Leeuwen, Flora E. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (13) :928-937